Neuroone Medical Technologies is trading 5.7% down at $1.87 after closing at $1.98 on August 27, 2026; no clear overnight catalyst was identified.
- The latest company announcement reported successful large-animal StereoCED procedures on August 27, but available coverage does not directly link the update to the pre-market drop.
- Broader futures are modestly weaker, but market moves are insufficient to establish a global-market cause.